Product
RNA analysis
5 clinical trials
9 indications
Indication
Prostate CancerIndication
Anaplastic Large Cell LymphomaIndication
Angioimmunoblastic T-cell LymphomaIndication
Hepatosplenic T-cell LymphomaIndication
Peripheral T-cell LymphomaIndication
Colorectal CancerIndication
Mantle Cell LymphomaIndication
lung cancerIndication
lymphomaClinical trial
Pre-Surgical EPS Biomarkers as Predictors of Biochemical RecurrenceStatus: Active (not recruiting), Estimated PCD: 2016-07-13
Clinical trial
A Phase II Study of Cyclophosphamide, Etoposide, Vincristine and Prednisone (CEOP) Alternating With Pralatrexate (P) as Front Line Therapy for Patients With Stage II, III and IV Peripheral T-Cell Non-Hodgkin LymphomaStatus: Completed, Estimated PCD: 2016-12-28
Clinical trial
Phase I Study of Ursodeoxycholic Acid (Ursodiol)in Combination With 5-Fluorouracil, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Metastatic Colorectal CancerStatus: Active (not recruiting), Estimated PCD: 2012-09-25
Clinical trial
A Phase II Study of Weekly Maintenance Bortezomib and Rituximab in Mantle Cell Lymphoma Post Autologous Hematopoietic Cell TransplantationStatus: Completed, Estimated PCD: 2020-11-02
Clinical trial
Tissue Acquisition for Analysis of Prognostic Factors, Immunology, and Genetic Progression of HIV-1 Associated MalignanciesStatus: Terminated, Estimated PCD: 2022-01-14